Skip to content
Blogs
FEATURED | May 1, 2025

Why I’m Getting Naked for Skin Health 

Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...

3 Minute Read
Blogs |
November 25, 2015

Julie & Amelia – #GivingTuesday 2015

#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF.   #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...

2 Minute Read
Press Release |
November 12, 2015

Guest Post: Dr. Sacks, Ocular Melanoma and Gratitu...

Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude.

3 Minute Read
Blogs |
November 10, 2015

FDA Approves New Targeted Therapy Combination (Vem...

Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...

4 Minute Read
Blogs |
November 6, 2015

Washington, D.C. Community Combats Melanoma at 7th...

Washington, D.C. – On Saturday, November 7th, the Washington, D.C. melanoma community will come together to honor those who have been impacted by melanoma and raise f...

4 Minute Read
Press Release |
October 30, 2015

#CUREOM Unite! – Thank You!

The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (O...

2 Minute Read
Blogs |
October 27, 2015

FDA Approves First New Adjuvant Treatment for Stag...

Statement from Tim Turnham, Executive Director, Melanoma Research Foundation   Washington, D.C.—Today the Food and Drug Administration (FDA) approved ipilimumab ...

3 Minute Read
Press Release |
October 27, 2015

FDA Approves Talimogene Laherparepvec (T-VEC) for ...

Today the FDA approved Amgen’s drug, Imlygic (Talimogene Laherparepvec or T-VEC), for the treatment of unresectable Stage IIIB, IIIC or IV metastatic melanoma, bringing a...

3 Minute Read
Blogs |
October 14, 2015

Guest Post: Dr. Richard Carvajal – #CUREOM U...

For the last decade, Dr. Richard Carvajal has dedicated his career to the research and treatment of rare cancers like ocular melanoma (OM) and understands the need for more...

2 Minute Read
Press Release |
October 6, 2015

Guest Post: Connie’s Story

Guest blogger Connie Popp shares her experience as an ocular melanoma caregiver, advocate and participant in Miles for Melanoma in support of the CURE OM Unite! campaign. 3 Minute Read

Blogs |
September 30, 2015

FDA Approves Opdivo and Yervoy Combination for Adv...

  Statement from Tim Turnham, Executive Director, Melanoma Research Foundation   The Melanoma Research Foundation (MRF) applauds the FDA’s approval of the c...

3 Minute Read
Press Release |
September 4, 2015

World Champion Athlete Joins Fight Against Melanom...

Leanda Cave Partners with the Melanoma Research Foundation to Raise Awareness of the Deadliest Form of Skin Cancer   WASHINGTON, D.C.— Four-time Triathlon World ...

4 Minute Read
Melanoma News |
September 1, 2015

The MRF Urges Administration to Take Measures to P...

The Melanoma Research Foundation submitted a letter to the Office of Management and Budget (OMB) urging it to take the critical step toward reducing skin cancers. The Food ...

1 Minute Read

May 10, 2025

The Ohio State University Patient and Caregiver Symposium

May 10, 2025

Stay Out of the Sun Run

May 10, 2025

Miles for Melanoma New England, MA

May 17, 2025

Mayo Clinic Patient and Caregiver Symposium

May 17, 2025

Melanoma Clinic Walk

May 20, 2025

Ask the Expert: Understanding Melanoma: Risk Factors, Screening Data and Sun Safety Best Practices

May 30, 2025 - Jun 03, 2025

ASCO

Explore Events